Skip to main content
. Author manuscript; available in PMC: 2020 Jun 26.
Published in final edited form as: Alzheimers Dement. 2019 Nov 18;15(12):1507–1515. doi: 10.1016/j.jalz.2019.08.202

Table 2.

Mild cognitive impairment participants’ characteristics between Hispanic/Latino backgrounds

Dominican Central American Cuban Mexican Puerto Rican South American Total P value
Age (years), % (SE)
 50–59 32.08 (7.81) 37.78 (7.31) 23.66 (6.05) 28.68 (4.27) 28.64 (5.50) 32.57 (8.88) 28.90 (2.59) .960
 60–69 35.45 (6.97) 26.73 (6.37) 38.05 (6.31) 35.80 (4.86) 33.00 (5.37) 27.15 (8.67) 34.42 (2.74)
 70+ 32.47 (8.38) 35.49 (9.52) 38.29 (7.79) 35.52 (5.86) 38.36 (6.57) 40.28 (10.94) 36.68 (3.26)
Education (years), % (SE)
 <12 47.52 (7.93) 60.47 (7.73) 28.03 (5.61) 59.92 (5.15) 56.00 (6.09) 26.18 (10.55) 49.30 (2.82) .002
 12 15.25 (6.34) 11.63 (4.93) 23.55 (5.79) 17.19 (3.68) 19.48 (4.97) 18.60 (8.45) 18.46 (2.19)
 >12 37.23 (8.08) 27.91 (5.84) 48.42 (6.43) 22.89 (4.68) 24.52 (5.42) 55.21 (11.44) 32.24 (2.88)
Sex, % (SE)
 Female 68.66 (8.55) 62.47 (7.47) 62.19 (6.44) 50.61 (5.47) 61.44 (6.35) 57.94 (9.90) 58.51 (3.03) .411
Framingham cardiovascular risk score (FCRS), % (SE)
 <10% 23.16 (6.62) 17.82 (4.58) 13.13 (3.63) 22.30 (3.79)   8.38 (2.05) 43.27 (10.57) 18.21 (1.79) .017
 10–<20% 35.03 (7.03) 25.21 (5.88) 28.17 (6.85) 33.34 (4.71) 35.95 (6.19) 34.97 (9.22) 32.33 (2.69)
 20+% 41.81 (7.66) 56.97 (7.45) 58.70 (6.96) 44.35 (5.68) 55.67 (6.37) 21.76 (7.98) 49.46 (2.98)
APOE4 Status, % (SE)
 Any 4 24.87 (8.58) 28.53 (10.85) 23.76 (6.91) 21.05 (5.82) 25.30 (6.32) 14.75 (7.06) 23.45 (2.96) .947
Age (years), Mean (SD) 65.19 (8.20) 65.19 (10.51) 66.23 (6.64) 66.07 (9.15) 66.63 (9.04) 65.56 (9.93) 66.04 (8.73) .97
FCRS (r = 0%–100%), Mean (SD)   22.0 (14.0)   24.0 (16.0)   29.0 (15.0)   25.0 (20.0)   26.0 (16.0)   18.0 (18.0)   25.0 (18.0) .09
CESD-10 (r = 0–30), Mean (SD)   9.32 (6.85)   7.68 (8.07)   9.38 (5.83)   7.52 (6.43) 12.00 (6.31) 10.60 (9.25)   9.21 (6.94) <.0001

Abbreviations: SD, standard deviation; SE, standard error; CESD, Center for Epidemiologic Studies Depression; APOE4, Apolipoprotein E4.

Results are based on data from Hispanics/Latinos aged 50–86 years in the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).